The Europe Coated Endotracheal Tube Market would witness market growth of 5.9% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 2,358.7 thousand units, showcasing a growth of 8.7% (2019-2022).
The hydrophilic nature of certain coatings reduces friction, easing the insertion and removal of the tube and enhancing patient comfort during prolonged ventilation periods. Some coatings' anti-microbial properties help prevent ventilator-associated pneumonia (VAP), a common complication of prolonged intubation. This is crucial for patients in the ICU who are already susceptible to infections. These tubes are available in smaller sizes suitable for pediatric patients. This ensures a better fit and reduces the risk of complications in children, addressing the unique challenges of airway management in the pediatric population.
The market is witnessing a shift towards developing and utilizing advanced materials for tube coatings. Manufacturers are exploring materials with enhanced biocompatibility, durability, and specific functionalities to improve the overall performance of these tubes. There is a growing trend toward customization, with these tubes being developed to address the unique needs of specific patient populations. This includes variations in coatings tailored for different age groups, comorbidities, and medical procedures.
As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. Additionally, according to a report on the French aging policy published by the UN, as in other European countries, France faces a continuous and significant increase in elderly people. The nation had 15 million people aged more than 60 in France in 2012, expected to reach 24 million in 2060. The factors mentioned above will drive the regional market growth.
The Germany market dominated the Europe Coated Endotracheal Tube Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $15,359.1 Thousands by 2030. The UK market is exhibiting a CAGR of 4.9% during (2023 - 2030). Additionally, The France market would experience a CAGR of 6.7% during (2023 - 2030).
Based on Intubation, the market is segmented into Orotracheal and Nasotracheal. Based on End User, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centers. Based on Application, the market is segmented into Anesthesia, Emergency Medicine, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Coated Endotracheal Tube Market will Hit $238.2 Million by 2030, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sonoma Pharmaceuticals Inc., Becton, Dickinson, and Company, Bactiguard Holding AB (publ), Sharklet Technologies, Inc., Medline Industries, LP, N8 Medical, LLC, Armstrong Medical Ltd (Eakin Healthcare Ltd), Teleflex, Inc. and Venner Medical (Deutschland) GmbH.
By Intubation (Volume, Thousand Units, USD Million, 2019-2030)
By End User (Volume, Thousand Units, USD Million, 2019-2030)
By Application (Volume, Thousand Units, USD Million, 2019-2030)
By Country (Volume, Thousand Units, USD Million, 2019-2030)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.